Delivery Order SPE2DB20D3101-SPE2DB21FK4M8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,934.70 fixed-price delivery order covers the supply of the medication Myrbetriq ER 25 mg tablets. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,953.88 firm fixed-price delivery order is for the pharmaceutical product Myrbetriq ER 25 mg Tablet 90s. The award has an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, with a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of pharmaceutical products, including Myrbetriq ER 25 mg tablets, to support military healthcare programs. The contract has a ceiling value of $78,661.55 and a completion date of August 13, 2021. This is a firm fixed-price delivery order contract, and there is no set-aside designation...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA) under a firm-fixed price delivery order. The $16,594.29 contract, awarded on April 12, 2022, has an ultimate completion date of April 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,120.91 firm fixed-price delivery order is for the medication Myrbetriq ER 50 mg tablet, with an ultimate completion date of October 29, 2021. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,885.50 firm fixed-price delivery order is for the supply of Myrbetriq ER 25 mg tablets and has an ultimate completion date of July 28, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,862.84 firm-fixed-price delivery order is for the pharmaceutical product Myrbetriq ER 25 mg tablets. The contract has an ultimate completion date of October 30, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and wholly-owned subsidiary of Cencora, Inc. The $28,159.98 firm-fixed-price delivery order is for Myrbetriq ER 50 mg tablets to be delivered by June 2, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
- This federal contract award, valued at $25,253.32, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication Myrbetriq ER 25 mg Tablet, with a completion date of September 1, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- This federal contract award, valued at $33,645.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication Myrbetriq ER 50 mg tablet, with a completion date of May 31, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB21FK4M8Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,059.84 firm-fixed-price delivery order is for the drug Myrbetriq ER 25 mg tablets and has a completion date of September 7, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have a set-aside designation, indicating open competition. The contract supports the DLA's role in procuring essential medical commodities for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $67.1k | 9/3/21 |